期刊文献+

鸭肝组织中DHBV cccDNA的实时荧光定量PCR方法的建立 被引量:1

Development and Validation of Quantitative Duck Hepatitis B Virus cccDNA PCR Assays in Duck Liver Tissue
下载PDF
导出
摘要 目的 建立基于DHBV病毒正、负链缺口区设计引物、沉淀蛋白结合的DNA、酶切消化残留线性DNA的DHBVcccDNA荧光定量PCR方法.方法 根据DHBV cccDNA和rcDNA结构的不同,将引物设计在DHBV DNA负链缺口的两侧.采用十二烷基硫酸钾蛋白质沉淀法分离肝组织中cccDNA和rcDNA.并对提取的DNA进行紫外定量,按照每2UPSAD消化500ng cccDNA,计算PSAD的用量,酶切消化残存的线性DNA.以pBR322/2DHBV Core重组质粒为PCR标准品,通过优化反应体系和扩增条件,建立检测DHBV cccDNA的SYBR Green I实时荧光定量PCR方法,并进行方法学考察和实际应用.结果 优化的PCR扩增产物电泳后可见239 bp的DNA片段,与目标片段长度相同.标准曲线回归方程Y=-4.085 7X+48.805,R2=-0.997 6.方法的灵敏度为103 copies/ml,线性范围可达103~108 copies/ml.方法特异性强,未检出DHV,HBV及E coli DNA.对已感染DHBV的鸭肝组织检测DHBV cccDNA,进行定量,含量从0.36~1733.08 copies/diploid genome.其中分布最广的是10~99 copies/dioploid genome.DHBV cccDNA占总DHBV DNA的比例平均仅为3.86%,范围从0.01%~13.3s%.结论 根据DHBV cccDNA与rcDNA的结构和理化性质的差异,设计能够特异性扩增DHBV cccDNA的荧光定量PCR方法,方法灵敏度高、特异度强,可广泛应用于DHBV和HBV抗病毒治疗策略的相关研究中. Objective To develop a Taqman real time fluorescent quantitative PCR assay for duck hepatitis B virus (DHBV) cccDNA,based on the gap region of positive and negative strand of DHBV DNA and prepared the samples by the precipitati on of protein binding DNA and the digestion of linear DNA.Methods According to the structure of DHBV cccDNA and rcDNA,the primers were designed to locate at the sides of the gap of negative strand of DHBV DNA.After the isolation of DHBV cccDNA and rcDNA from liver tissue by protein precipitation used dodecyl sulfate,linear DNA was digested by en zyme according to the digestion of 500 ng of cccDNA by 2U PSAD.The recombinant plasmid of pBR322/2DHBV Core gene was used to generate DHBV DNA standard.By optimizing the reaction system and amplification conditions,the SYBR Green I real time fluorescent quantitative PCR assay for DHBV cccDNA was developed,and methodological study was conducted.Results Optimized PCR amplification product was showed 239bp fragment by electrophoresis,which was the same length as the target fragment.The assay had a lowest detection limit of 103 copies/ml and a good linear standard curve (Y=-4.085 7X+48.805,R2=0.997 6) over a wide range of DHBV cccDNA levels (103 to 108 copies/ml).The specificity of the assaywas demonstrated by detecting duck hepatitis virus,HBV and E.coli DNA.Investigation of DHBV cccDNA of liver tissue from ducks infected by DHBV by the assay showed the content was from 0.36 to 1 733.08 copies/diploid genome,and the most widely distribution was 10~99 copies/dioploid genome.The proportion of DHBV cccDNA to total DHBV DNA was only 3.86% on average,ranging from 0.01% to 13.38%.Conclusion The FQPCR developed is highly sensitive and specif ic,and can be widely used in the research of anti DHBV or HBV treatment strategies.
出处 《现代检验医学杂志》 CAS 2014年第4期1-4,172,共5页 Journal of Modern Laboratory Medicine
基金 国家自然科学基金资助,项目批准号:81101260.
关键词 鸭乙肝病毒 CCCDNA 实时荧光定量PCR duck hepatitis B virus (DHBV) covalently closed circular DNA (cccDNA) real-time fluorescent quantitative PCR
  • 相关文献

参考文献16

  • 1Dienstag JL.Hepatitis B virus infection[J].New Eng-land Journal of Medicine,2008,359 (14):1486-1500.
  • 2Dandri M,Volz TK,Luetgehetmann M,et al.Animalmodels for the study of HBV replication and its variants[J].Journal of Clinical Virology,2005,34 (1):S54-S62.
  • 3Mason WS,Seal G,Summers J.Virus of pekin ducks with structural and biological relatedness to human hepatitis B virus[J].Journal of Virology,1980,36(3):829-836.
  • 4Schultz U,Grgacic E,Nassal M.Duck hepatitis B virus:an invaluable model system for HBV infection[J].Advances in Virus Research,2004 (63):1-70.
  • 5Bishop N,Civitico G,Wang YY,et al.Antiviral strategies in chronic hepatitis B virus infection:Ⅰ.Establishment of an in vitro system using the duck hepatitis B virus model[J].Journal of Medical Virology,1990,31(2):82-89.
  • 6Seeger C,Mason WS.Hepatitis B virus biology[J].Microbiology and Molecular Biology Reviews,2000,64(1):51-68.
  • 7Nassal M,Schaller H.Hepatitis B virus replication[J].Trends in Microbiology,1993,1 (6):221-228.
  • 8Grimm D,Thimme R,Blum HE.HBV life cycle and novel drug targets[J].Hepatology International,2011,5(2):644-653.
  • 9Werle-Lapostolle B,Bowden S,Locarnini S,et al.Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy[J].Gastroenterology,2004,126 (7):1750-1758.
  • 10Wu TT,Coates L,Aldrich CE,et al.In hepatocytes infected with duck hepatitis B virus,the template for viral RNA synthesis is amplified by an intracellular pathway[J].Virology,1990,175 (1):255-261.

同被引文献24

  • 1European Association For The Study of The Liver.EASL clinical practice guidelines:Management of chronic hepatitis B virus infection[J].J Hepatol,2012,57(1):167-185.
  • 2Seeger C,Mason W S.Hepatitis B virus biology[J].Microbiol Mol Biol Rev,2000,64(1):51-68.
  • 3Nassal M,Schaller H.Hepatitis B virus replication[J].Trends Microbiol,1993,1(6):221-228.
  • 4Grimm D,Thimme R,Blum H E.HBV life cycle and novel drug targets[J].Hepatol Int,2011,5(2):644-653.
  • 5Chang T T,Lai C L,Chien R N,et al.Four years of lamivudine treatment in Chinese patients with chronic hepatitis B[J].J Gastroenterol Hepatol,2004,19(11):1276-1282.
  • 6Rizzetto M,Tassopoulos N C,Goldin R D,et al.Extended lamivudine treatment in patients with HBeAgnegative chronic hepatitis B[J].J Hepatol,2005,42(2):173-179.
  • 7Fung J,Lai C L,Yuen M F.LB80380:apromising new drug for the treatment of chronic hepatitis B[J].Expert Opin Investig Drugs,2008,17(10):1581-1588.
  • 8Lok A S,Lai C L,Leung N,et al.Long-term safety of lamivudine treatment in patients with chronic hepatitis B[J].Gastroenterology,2003,125(6):1714-1722.
  • 9Dandri M,Volz T K,Lütgehetmann M,et al.Animal models for the study of HBV replication and its variants[J].J Clin Virol,2005,34Suppl 1:S54-62.
  • 10Mason W S,Seal G,Summers J.Virus of Pekin ducks with structural and biological relatedness to human hepatitis B virus[J].J Virol,1980,36(3):829-836.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部